Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium tuberculosis membrane transport refers to the collection of specialized systems and proteins that facilitate the movement of nutrients, metabolites, ions, and drugs across the unique and highly impermeable cell envelope of Mtb. This process is critical for bacterial survival, adaptation within host environments, drug resistance, and pathogenesis. Key components include PE/PPE family proteins involved in nutrient uptake (e.g., PPE51 for propionamide, glucose, glycerol; PE15/PPE20 for calcium), MmpL family lipid transporters (e.g., for TMM, PDIMs), and efflux pumps that mediate drug resistance. Due to their essential roles and contribution to drug resistance, these transport systems represent promising targets for novel anti-TB therapeutics.
Inhibition of nutrient uptake, disruption of cell wall biosynthesis, inhibition of drug efflux
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis Membrane Transport Systems (Mtb Membrane Transport).